openPR Logo
Press release

Direct-acting Antiviral Drugs Market Size, Share, Growth, Forecast | Valuates Reports

01-27-2023 06:38 PM CET | Advertising, Media Consulting, Marketing Research

Press release from: Valuates Reports

Direct Actting Antiviral Drugs Market

The global Direct-acting Antiviral Drugs market size is projected to reach US$ million by 2028, from US$ million in 2021, at a CAGR of % during 2022-2028.

Fully considering the economic change by this health crisis, NS3/4A Protease Inhibitors accounting for % of the Direct-acting Antiviral Drugs global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period.

Download Sample Report: https://reports.valuates.com/request/sample/QYRE-Auto-11O2087/Global_Direct_acting_Antiviral_Drugs_Market_Insights_Forecast_to_2028

While Hospitals segment is altered to an % CAGR throughout this forecast period.

China Direct-acting Antiviral Drugs market size is valued at US$ million in 2021, while the North America and Europe Direct-acting Antiviral Drugs are US$ million and US$ million, severally. The proportion of the North America is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period.

As for the Europe Direct-acting Antiviral Drugs landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Direct-acting Antiviral Drugs market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Direct-acting Antiviral Drugs market in terms of revenue.

Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Direct-acting Antiviral Drugs market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Direct-acting Antiviral Drugs market.

Direct-acting Antiviral Drugs market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Direct-acting Antiviral Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.

By Type
• NS3/4A Protease Inhibitors
• Nucleoside and Nucleotide NS5B Polymerase Inhibitors
• NS5A Inhibitors
• Non-Nucleoside NS5B Polymerase Inhibitors

By Application
• Hospitals
• Clinics
• Ambulatory Surgical Centers
• Pharmacies
• Others

By Company
• AbbVie Inc.
• GSK
• Boehringer Ingelheim
• Merck
• Novartis
• Beximco Pharmaceuticals
• Roche
• Bristol-Myers Squibb Company
• Gilead Sciences
• Janssen (Johnson & Johnson)
• Vertex Pharmaceuticals
• Natco Pharma

View Full Report: https://reports.valuates.com/market-reports/QYRE-Auto-11O2087/global-direct-acting-antiviral-drugs

Similar Reports:

1. HIV Therapeutics Market: https://reports.valuates.com/market-reports/QYRE-Auto-22W5974/global-hiv-therapeutics

2. Antiviral Therapy Market: https://reports.valuates.com/market-reports/QYRE-Auto-2G10409/global-antiviral-therapy

3. Influenza Antiviral Drugs Market: https://reports.valuates.com/market-reports/QYRE-Auto-8J2211/global-influenza-antiviral-drugs

4. Influenza Diagnostics Market: https://reports.valuates.com/reports/QYRE-Auto-13Z613/global-influenza-diagnostics

5. Antiviral Drugs Industry: https://reports.valuates.com/market-reports/QYRE-Othe-2E265/global-antiviral-drugs

Phone:
U.S. (TOLL FREE) : +1 (315) 215-3225
India: +91 8040957137

Email Id:
Please reach us at sales@valuates.com

Address:
Valuates,
4th Floor,
Balaraj's Arcade,
Whitefield Main road,
Bangalore 560066,

Valuates offers an extensive collection of market research reports that helps companies to take intelligent strategical decisions based on current and forecasted Market trends.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Direct-acting Antiviral Drugs Market Size, Share, Growth, Forecast | Valuates Reports here

News-ID: 2902476 • Views: 288

More Releases from Valuates Reports

Military Tank Containers Market Size, Share, Revenue, Growth, Forecast, Segmenta …
Military Tank Containers Market Military tank containers are used to transport water and fuel to remote locations where scarcity of water and fuel prevails. These tank containers also carry food and medicine for the military personnel at remote areas as well as in the battleground. The military tank containers are built to perform high speed operations on rocky and rough roads and can also traverse rough terrain. Defense forces across the
Smart Medicine Compounding Robot Market Size, Share, Revenue, Forecast, Analysis
Smart Medicine Compounding Robot Market Due to the COVID-19 pandemic, the global Smart Medicine Compounding Robot market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the review period. Fully considering the economic change by this health crisis, the Europe Smart Medicine Compounding Robot market is estimated at US$ million in 2022, while
2-Ethylhexyl Methacrylate Market, Size, Share, Growth, Report | Valuates Reports
Ethylhexyl Methacrylate 2 Market 2-Ethylhexyl methacrylate (2-EHMA), is a main methacrylic ester and polymerizable monomer. 2-EHMA is produced for the use as a building block to make a wide range of polymer based products that we see and use every day from paints and coatings, toners and inks, oil additives to dental and medical products to name but a few. 2-EHMA is of low concern to human health and the environment. It
Poly Aluminium Chloride Market, Size, Revenue, Share, Forecast
Polyaluminium Chloride Market Polyaluminium chloride (PAC) is manufactured in both liquid and powder form. The product is used in deodorants and antiperspirants, as a flocculant in water purification, in treatment of drinking / potable water, wastewater treatment and paper sizing. In this report, poly alumnium chloride is classified into liquid and powder type. All the poly alumnium chloride products are converted into 30% Al2O3 content. Due to the COVID-19 pandemic, the global

All 5 Releases


More Releases for Antiviral

Antiviral Drugs Market Size, Report 2022-2030
Acumen Research and Consulting has announced the addition of the "Antiviral Drugs Market" report to their offering. The Antiviral Drugs Market Report 2030 is an in depth study analyzing the current state of the Antiviral Drugs Market. It provides brief overview of the market focusing on definitions, market segmentation, end-use applications and industry chain analysis. The study on Antiviral Drugs Market provides analysis of global market covering the industry trends, recent
Antiviral Drugs Market
“Antiviral Drugs Market” study by “The Insight Partners” provides details about the market dynamics affecting the market, Market scope, Market segmentation and overlays shadow upon the leading market players highlighting the favorable competitive landscape and trends prevailing over the years. This Report encloses comprehensive analysis on the market and are assessed through volume and value data validated on three approaches including top companies revenues. It concludes with precise and authentic market
Antiviral therapies Market: High Cost of Antiviral therapies Is a Major Restrain …
Post COVID-19 Impact on Antiviral Therapies Market –With the emergence of the COVID-19 crisis, the world is fighting a health pandemic as well as an economic emergency, almost impacting trillions of dollars of revenues. Research Dive’ group of skilled analysts provide a solution to help the companies to survive and sustain in this economic crisis. We support companies to make informed decisions based on our findings resulting from the comprehensive
Increasing Utilization of Antiviral Drugs, During the COVID-19 Outbreak, to Prom …
According to antiviral therapies market analysis by Research Dive, the global market forecast will surpass $66,016.5 million in 2027, growing at a 3.1% CAGR from $51,913.1 million in the year2019. Antiviral Therapies Market, COVID-19 Impact: The global antiviral therapies market has responded positively to the pandemic owing to rise in the utilization of antiviral drugs in the development of effective medicines for the COVID-19 treatment. In addition, leading players in the global
Coronavirus's Impact On Antiviral Packaging Market
Antiviral Packaging Market – An Overview The coronavirus pandemic keeps on revamping the idea of worldwide society in 2020, and with it changes the perspectives and practices of buyers now and for a long time to come. In any case, the prompt effect on buyers’ interests about viral introduction and questions hanging about the infection’s capacity to make due on surfaces, may fuel an any longer enduring interest for new bundling
Magniflex Introduces Antiviral and Antibacterial Collection
Magniflex, the renowned mattress manufacturer from Italy, has always had innovation in its DNA, as the success, accolades, and certifications obtained over the years prove, and the goal has always been to introduce innovative solutions to common issues that affect the quality of our sleep. As a response to the COVID-19 global pandemic, Magniflex conducted scientific and technological research in collaboration with prominent experts in order to produce MagniProtect: an